WAKO DIRECT BILIRUBIN V— 510(k) K970986

Substantially Equivalent

Wako Chemicals USA, Inc.

FDA 510(k) clearance K970986 for WAKO DIRECT BILIRUBIN V, Substantially Equivalent on 1997-05-07. Applicant: Wako Chemicals USA, Inc..

Clearance details

Applicant: Wako Chemicals USA, Inc.
Product code: Code CIG
Advisory panel: Clinical Chemistry
Date received: 1997-03-18
Decision date: 1997-05-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Richmond, VA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.